Date
Title
Date
04/21/26
Title
Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting
Date
04/20/26
Title
Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026
Date
03/18/26
Title
Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026
Date
03/17/26
Title
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results
Date
02/03/26
Title
Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline